BWAY Brainsway Ltd. IFRS
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1505065
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2020Q4*2020-12-31 | 2019Q4*2019-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $7.07M | $6.29M |
| Cost of revenue | $1.57M | $1.44M |
| Gross profit | $5.50M | $4.85M |
| R&D expense | $1.58M | $1.81M |
| SG&A expense | $1.33M | $1.43M |
| Operating income | -$9.25M | -$14.96M |
| Interest expense | $239,000 | $178,000 |
| Pretax income | -$9.65M | -$17.64M |
| Income tax | -$240,000 | $147,000 |
| Net income | -$406,000 | -$2.32M |
| EBITDA | -$9.02M | -$14.62M |
| EPS (diluted) | — | — |
| Balance sheet | ||
| Cash & equivalents | $16.96M | $21.67M |
| Receivables | $5.58M | $5.51M |
| Current assets | $24.30M | $28.83M |
| PP&E, netmay include right-of-use assets (IFRS) | $4.35M | $4.25M |
| Total assets | $34.01M | $38.74M |
| Current liabilities | $6.80M | $6.72M |
| Total liabilities | $14.38M | $14.52M |
| Shareholders' equity | $19.63M | $24.22M |
| Shares outstanding | 22.25M | 22.24M |
| Cash flow statement | ||
| Operating cash flow | $1.64M | -$1.23M |
| Capital expenditure | -$85,000 | $338,000 |
| Free cash flow | $1.73M | -$1.57M |
| Investing cash flow | $85,000 | -$396,000 |
| Financing cash flow | -$750,000 | -$414,000 |
| Depreciation & amortization | $228,000 | $340,000 |
| Stock-based compensation | $128,000 | $282,000 |
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.